Medicinal products for the alimentary tract and metabolism (Испания - Тендер #41142220)

1. Section I
   1. Name and addresses
      Institut d"Investigació Biomèdica de Bellvitge (IDIBELL)
      Avinguda Gran Via de Hospitalet, 199 - Hospital Duran i Reynals, 2a planta
      Hospitalet de Llobregat
      08908
      Spain
      Telephone: +34 936073800
      E-mail: contractacio@idibell.cat
      
   2. Joint procurement
      
   3. Communication
      The procurement documents are available for unrestricted and full direct access, free of charge, at
      https://contractaciopublica.cat/ca/perfils-contractant/detall/5624359?categoria=0
      Additional information can be obtained from the abovementioned addresselectronically via: https://contractaciopublica.cat/ca/perfils-contractant/detall/5624359?categoria=0
      to the abovementioned address
      
   4. Type of the contracting authority:
      Other type: Fundación Pública - Poder Adjudicador no Administración Pública
      
   5. Main activity:
      Other activity: Investigación
      
2. Section II
   1. Scope of the procurement:
      1. Title:
         

         Adquisición del medicamento Skilarence, fabricación de placebo, acondicionamiento, almacenamiento y gestión de distribución a los centros participantes del ensayo clínico

         Reference number: PCP-2307
         
      2. Main CPV code:
         33610000
         
      3. Type of contract:
         Supplies
         
      4. Short description:
         

         Adquisición del medicamento Skilarence, fabricación de placebo, acondicionamiento, almacenamiento y gestión de distribución a los servicios de farmacia de los centros participantes del ensayo clínico

      5. Estimated total value:
         Value excluding VAT: 394 200.00 EUR
         
      6. Information about lots:
         all lots
   2. Description
      1. Title:
         

         Medicación Skilarence

         Lot No: 1
         
      2. Additional CPV code(s):
         33610000
         
      3. Place of performance:
         
      4. Description of the procurement:
         

         Suministro del medicamento Skilarence

      5. Award criteria:
         Cost criterion - Weighting: 100
         
      6. Estimated value:
         Value excluding VAT: 318 700.00 EUR
         
      7. Duration of the contract, framework agreement or dynamic purchasing system:
         
         Start: 2023-06-12
         End: 2025-12-15
         This contract is subject to renewal: yes
         Description of renewals:

         Se prevé una prórroga de 12 meses en caso de ampliación del plazo de ejecución del proyecto de referencia FIS21127 – ICI21/00085. Esta prórroga no supondrá un incremento del importe de licitación.

      8. Information about the limits on the number of candidates to be invited:
         
      9. Information about variants:
         Variants will be accepted: no
         
      10. Information about options:
          Options: no
      11. Information about electronic catalogues:
          
          
      12. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds:

          Este contrato está subvencionado por el Instituto de Salud Carlos III, financiado por la Unión Europea – NextGenerationEU. Con el apoyo institucional de CERCA Programme / Generalitat de Catalunya

      13. Additional information:
          
      14. Title:
          

          Fabricación de Placebo y suministro de la medicación y del placebo con destino al servicio de farmacia de los diferentes centros participantes en el ensayo clínico y destrucción de la medicación res

          Lot No: 2
          
      15. Additional CPV code(s):
          33610000
          
      16. Place of performance:
          
      17. Description of the procurement:
          

          Fabricación de Placebo y suministro de la medicación y del placebo con destino al servicio de farmacia de los diferentes centros participantes en el ensayo clínico y destrucción de la medicación restante

      18. Award criteria:
          Quality criterion - Name: Control de calidad / Weighting: 20
          Cost criterion - Weighting: 80
          
      19. Estimated value:
          Value excluding VAT: 75 500.00 EUR
          
      20. Duration of the contract, framework agreement or dynamic purchasing system:
          
          Start: 2023-06-12
          End: 2025-12-15
          This contract is subject to renewal: yes
          Description of renewals:

          Prórroga adicional de 12 meses en caso de ampliación del plazo de ejecución del proyecto, desde el 16 de diciembre de 2025 hasta el 15 de diciembre de 2026

      21. Information about the limits on the number of candidates to be invited:
          
      22. Information about variants:
          Variants will be accepted: no
          
      23. Information about options:
          Options: no
      24. Information about electronic catalogues:
          
          
      25. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds:

          Este contrato está subvencionado por el Instituto de Salud Carlos III, financiado por la Unión Europea – NextGenerationEU. Con el apoyo institucional de CERCA Programme / Generalitat de Catalunya.

      26. Additional information:
          
3. Section III
   1. Conditions for participation:
      1. Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers:
         
      2. Economic and financial standing:
         Selection criteria as stated in the procurement documents
      3. Technical and professional ability:
         Selection criteria as stated in the procurement documents
      4. Information about reserved contracts:
         
   2. Conditions related to the contract:
      1. Information about a particular profession:
         Contract performance conditions:

         Consideraciones de tipo medioambiental.

         La empresa adjudicataria adoptará las medidas oportunas para el cumplimiento de la legislación medioambiental vigente que sea de aplicación.

      2. Information about staff responsible for the performance of the contract:
         
4. Section IV
5. Description:
   1. Type of procedure:
      Open procedure
   2. Information about a framework agreement or a dynamic purchasing system:
      
   3. Information about reduction of the number of solutions or tenders during negotiation or dialogue:
      
   4. Information about negotiation:
      
   5. Information about electronic auction:
      
   6. Information about the Government Procurement Agreement (GPA):
      The procurement is covered by the Government Procurement Agreement: no
6. Administrative information:
   1. Previous publication concerning this procedure:
      
   2. Time limit for receipt of tenders or requests to participate:
      Date: 2023-05-31
      Local time: 13:00
      
   3. Estimated date of dispatch of invitations to tender or to participate to selected candidates:
      
   4. Languages in which tenders or requests to participate may be submitted:
      CA, ES
   5. Minimum time frame during which the tenderer must maintain the tender:
      (from the date stated for receipt of tender)
      
   6. Conditions for opening of tenders:
      Date: 2023-06-01
      Local time: 10:00
      

Источник закупки

Импорт - Экспорт по стране Испания